Creative Medical Technology (NASDAQ:CELZ) stock is taking off on Monday despite a lack of news from the commercial-stage biotechnology company.
So if there’s no news from Creative Medical Technology, then why is CELZ stock up today? It looks like investors have retail and day traders to thank for the rising price of CELZ stock this morning.
There’s been plenty of chatter concerning CELZ stock on social media this morning. That includes several day traders with large followings Tweeting about the stock. The following are just a few examples of that.
CELZ Stock Twitter Talk
$CELZ Up 44% in pre pre market trading with almost 1m a trade in a float of 2m! Whoa!! This is going to be a mega runner!! #SmallCaps
— BMoe (@BMoeKnows) January 3, 2022
Just about every stock is up right now.
Hard to find anything cheap.$CELZ
Stock trdae I discovered 2 weeks ago that went up 150% and we dumped is getting pumped again.
great if you went back in lower after the dump.
Same thing will happen again. They will end up dumping it. pic.twitter.com/MYjHd41Ymk— Brian Jones (@TraderBJones) January 3, 2022
If you listened to me on the 30th you would of been up@ 95% this morning told ya 2022 we not playing no more 💪💪 $celz #CELZ pic.twitter.com/i5nXxgP4V9
— Treysingz (@Treysingz3) January 3, 2022
$CELZ GONE in premarket, already hit it’s float in volume before 6 am. We’ve been shouting from the rooftops for the past 2 weeks – hope you got in 😘 https://t.co/hvyvvsjloh
— KP (@Noted_Thanks_) January 3, 2022
$CELZ no one wanted it UNDER 2 😎😎😎😎😎😎😎😎 pic.twitter.com/lGcfucj9sE
— Tommy Coops (@ohheytommy) January 3, 2022
Of course, traders will want to be careful about jumping into CELZ stock today. Today’s movement shows clear signs of a pump and dump that could leave some investors holding the bag. Adding to that is the company’s penny stock status.
Now let’s cover what traders need to know about CELZ stock today!
- Creative Medical Technology is a commercial-stage biotechnology company focused on “Immunology, Urology, Neurology and Orthopedics.”
- That includes treatments for erectile dysfunction in men and sexual dysfunction in women.
- The company was founded in 1998 and operates out of its headquarter in Phoenix, Ariz.
- Leading the company is CEO Timothy Warbgington.
- The company’s current market capitalization is $19.931 million.
With the extra interest in CELZ stock today comes heavy trading. That has some 51 million shares of the move as of this writing. This is a major jump over its daily average trading volume of about 726,000 shares.
CELZ stock is up 38.8% as of Monday morning.
Investors on the lookout for more stock news today are in luck!
We’ve got all the most recent stock coverage traders need to know about for Monday! Among that is what has Armstrong Flooring (NYSE:AFI) stock up, a buyout offer for BlueCity Holdings (NASDAQ:BLCT), as well as Q4 results from Tesla (NASDAQ:TSLA). You can find all of that info at the links below!
More Monday Stock Market News
- AFI Stock Alert: 7 Things to Know About the Rumors Lifting Armstrong Flooring
- BLCT Stock: 7 Things to Know About LGBT Platform BlueCity Holdings and the Spriver Tech Deal
- Tesla Stock Looks Like a 2022 Winner After Its Q4 Delivery Beat
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
